CAS RN: 53617-35-9
4-Morpholinopiperidine
Product Availability
Choose a grade to view its available package options.
5 package records5 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20250827 |
100g |
In stock |
Shanghai, Shandong | Inquiry |
| Batchno.20260624 |
1g |
In stock |
Shandong | Inquiry |
| Batchno.20250711 |
25g |
In stock |
Shandong, Guangdong | Inquiry |
| Batchno.20250719 |
500g |
In stock |
Shanghai | Inquiry |
| Batchno.20250309 |
5g |
In stock |
Shanghai, Shandong, Guangdong | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 1g, 10g, 5g, 25g, 100g
- Available purity: ≥97%
- Inventory rows with stock: 2
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 53617-35-9
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 1g |
≥97% |
1
In Stock
|
Beijing |
Inquiry |
| 10g |
≥97% |
1
In Stock
|
Shanghai |
Inquiry |
| 5g |
≥97% |
0
Out of Stock
|
Shanghai |
Inquiry |
| 25g |
≥97% |
0
Out of Stock
|
Shanghai |
Inquiry |
| 100g |
≥97% |
0
Out of Stock
|
Beijing |
Inquiry |
53617-35-9 / 4-piperidin-4-ylmorpholine
Standard CAS: 53617-35-9
Multi CAS: Yes
Basic Information
CAS
53617-35-9
Multi CAS
Yes
Molecular Formula
C9H18N2O
Molecular Weight
170.250000
Exact Mass
170.141913
InChI
InChI=1S/C9H18N2O/c1-3-10-4-2-9(1)11-5-7-12-8-6-11/h9-10H,1-8H2
InChIKey
YYBXNWIRMJXEQJ-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
12
Fraction Csp3
1
Rotatable bonds
1
H-bond acceptors
3
H-bond donors
1
Molar refractivity
48.28
TPSA
24.5
LogP / Solubility
WLOGP
0.07
MLOGP
0.06
Consensus LogP
0.04
Log S (ESOL)
-0.87
Class (ESOL)
Very soluble
Log S (Ali)
-1.01
Class (Ali)
Soluble
Log S (SILICOS-IT)
-0.95
Class (SILICOS-IT)
Very soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-3.71
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
1.5